AGL38▲ 0.01 (0.00%)AIRLINK210.38▼ -5.15 (-0.02%)BOP9.48▼ -0.32 (-0.03%)CNERGY6.48▼ -0.31 (-0.05%)DCL8.96▼ -0.21 (-0.02%)DFML38.37▼ -0.59 (-0.02%)DGKC96.92▼ -3.33 (-0.03%)FCCL36.4▼ -0.3 (-0.01%)FFL14.95▲ 0.46 (0.03%)HUBC130.69▼ -3.44 (-0.03%)HUMNL13.29▼ -0.34 (-0.02%)KEL5.5▼ -0.19 (-0.03%)KOSM6.93▼ -0.39 (-0.05%)MLCF44.78▼ -1.09 (-0.02%)NBP59.07▼ -2.21 (-0.04%)OGDC230.13▼ -2.46 (-0.01%)PAEL39.29▼ -1.44 (-0.04%)PIBTL8.31▼ -0.27 (-0.03%)PPL200.35▼ -2.99 (-0.01%)PRL38.88▼ -1.93 (-0.05%)PTC26.88▼ -1.43 (-0.05%)SEARL103.63▼ -4.88 (-0.04%)TELE8.45▼ -0.29 (-0.03%)TOMCL35.25▼ -0.58 (-0.02%)TPLP13.52▼ -0.32 (-0.02%)TREET25.01▲ 0.63 (0.03%)TRG64.12▲ 2.97 (0.05%)UNITY34.52▼ -0.32 (-0.01%)WTL1.78▲ 0.06 (0.03%)

Thursday, December 26, 2024

Home Top News EU to end AstraZeneca, J&J vaccine contracts

EU to end AstraZeneca, J&J vaccine contracts

by News desk
April 16, 2021
in Top News

[tta_listen_btn]

News Desk

The EU Commission has decided not to renew Covid-19 vaccine contracts next year with AstraZeneca and Johnson & Johnson (J&J), Italian daily La Stampa reported on Wednesday, citing a source from the Italian health ministry.

“The European Commission, in agreement with the leaders of many (EU) countries, has decided that the contracts with the companies that produce (viral vector) vaccines that are valid for the current year will not be renewed at their expiry,” the newspaper reported.

It added that Brussels would rather focus on Covid-19 vaccines using messenger RNA (mRNA) technology, such as Pfizer’s and Moderna’s.